Automated Liquid Handling Robot

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q00158

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

NONE

Place of Performance

Laurel, Maryland, UNITED STATES

SourceSAM
The U.S. Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), is soliciting offers for the procurement of an automated liquid handling robot, as detailed under Solicitation Number 75F40126Q00158. This acquisition seeks to enhance the laboratory’s capabilities in automating critical workflows associated with long-read sequencing library preparation, specifically DNA shearing and AMPure bead cleanup processes. The intended outcome is to streamline and standardize sample preparation, thereby supporting the FDA CVM’s mission in veterinary research and regulatory science. The scope of this procurement encompasses the delivery of one (1) new and unused automated robotic liquid handling system. The system must be capable of processing up to 96 samples simultaneously in a 96-well plate format and must be fully interoperable with the government’s existing Pacific Biosciences (PacBio) Sequel IIe sequencing environment. Compatibility with validated laboratory workflows is essential, ensuring seamless integration into current operations. This requirement is being solicited as a brand-name-or-equal procurement, meaning that while the PacBio Sequel IIe is referenced, equivalent products will be considered provided they meet all salient characteristics, interoperability, workflow compatibility, and performance specifications as outlined in the solicitation. Key deliverables include: - Delivery and installation of the automated liquid handling system to the FDA CVM laboratory facility in Laurel, Maryland, within 60 days of contract award. - Operational verification to ensure the system functions as specified. - End-user training for a minimum of two users to facilitate effective adoption and operation. - Provision of consumables sufficient to process at least 200 samples. - A minimum 12-month manufacturer warranty covering the system. It is important to note that only new and unused equipment will be accepted; refurbished or remanufactured systems are expressly excluded from consideration. The procurement is classified under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6640. There are no set-aside restrictions associated with this solicitation, making it open to all qualified vendors. The place of performance is the FDA CVM facility located in Laurel, Maryland. The contracting activity is managed by the FDA Office of Acquisition and Grant Services, under the Department of Health and Human Services. Interested parties are encouraged to direct inquiries to the designated contacts: Reagan Davis ([email protected], 301-796-0910) and Iris Johnson ([email protected], 301-796-3353). This solicitation is currently active, with all responses to the latest amendment due by August 17, 2026, at 12:00 pm Eastern Time. The amendment clarifies that no further questions will be entertained and that all terms and conditions remain unchanged. Prospective offerors should review the attached questions and answers for additional context. Contractors evaluating this opportunity should ensure their proposed solution meets all interoperability, workflow, and performance requirements, and that they can fulfill the delivery, installation, training, and warranty obligations within the specified timeframe. This procurement represents a significant opportunity for vendors specializing in advanced laboratory automation solutions compatible with high-throughput sequencing environments. Further details and solicitation documents are available via the official SAM.gov posting at: https://sam.gov/opp/02a3508db27e4521a8582e1197134c40/view.
Documents6